Latest Asx News

Cedar Woods Properties has successfully extended its $330 million corporate finance facility, pushing the maturity of its three-year tranche to 2028 and its five-year tranche to 2030, reinforcing its financial stability.

Minbos Resources has officially commenced construction on its Cabinda Phosphate Fertilizer Project, supported by a robust US$36 million financing package from strategic partners including Angola’s Sovereign Wealth Fund and Banco BAI.

MPower Group has finalized the conversion of a $10 million project funding facility for its Narromine Renewable Energy Project into equity, with AMPYR Distributed Energy acquiring full ownership. The move strengthens MPower's balance sheet and supports its strategic push into hybrid renewable assets.

Classic Minerals Limited has agreed to sell its Kat Gap gold tenements to Bain Global Resources for A$7 million, aiming to reduce debt and refocus on other exploration projects. The deal awaits shareholder approval and regulatory clearances.

Altair Minerals has identified significant conductive and phase anomalies at its Olympic Domain Project, suggesting promising IOCG-style mineralisation near BHP’s Oak Dam deposit. The company plans advanced geophysical surveys to refine drill targets and accelerate exploration.

South Harz Potash Limited has made significant strides in acquiring the Sollstedt mine and secured approximately A$2.2 million in new equity, positioning itself to advance the Ohmgebirge project amid a strengthening potash market.

Rare Foods Australia reports an 18% biomass increase and $440k in cost savings, while launching its Subsea Estate brand and securing a $2.1M R&D refund to support growth.

RooLife Group (ASX: RLG) reported a striking 144% increase in sales revenue for Q2 FY2025, driven by the launch of new online stores across China, Hong Kong, Australia, and India. The company is investing heavily in product development and marketing to capitalize on booming health and wellness markets.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.

Jade Gas Holdings has made significant strides in its coal bed methane project in Mongolia, completing key wells and securing A$3.63 million to accelerate its gas production strategy targeting 2025 gas flows.

Elsight reported a robust 32% increase in annual revenue for 2024, driven by a strategic pivot towards the defense sector, which now accounts for over half of its total revenue. The company’s expanding customer base and debt elimination position it well for growth in 2025.

Audalia Resources has completed a key drilling program at its Medcalf Project, delineating promising mineralisation zones while significantly boosting its cash reserves through a recent capital raise.